RUNX3 and neoplasm: To further investigate the role of Runx3 in CD8 + T cells, we applied single-cell flow mass spectrometry analysis (CyTOF) and found that the proportion of CD8+ tumor infiltrating lymphocytes (TILs), changed significantly.